Inventor · disambiguated record
Robert Schmouder
Also filed as: SCHMOUDER ROBERT
2 granted patents·28 pending applications·7 citations·filing 2009–2024
55Inventor score
Top patents by PatentIndex Score
30 records- 0185US2025262171A1Dosage regimen for a s1p receptor agonistNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0284US10543179B2Dosage regimen of an S1P receptor modulatorNOVARTIS AG·Filed 2018·Granted Jan 28, 2020·7 cites·4 claims
- 0373US2023086687A1Dosage regimen of an s1p receptor modulatorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 0471US2022142949A1Dosage regimen for a s1p receptor agonistNOVARTIS AG·Filed 2021·Application pending·0 cites
- 0569US2011257133A1Dosage regimen for a s1p receptor agonistSCHMOUDER ROBERT·Filed 2009·Application pending·0 cites
- 0668US2021023027A1Paediatric Compositions For Treating Multiple SclerosisNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0766US2020197334A1Paediatric Compositions For Treating Multiple SclerosisNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0866US2020330407A1Dosage regimen for a s1p receptor agonistNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0966US2018289638A1Dosage regimen for a s1p receptor agonistNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1066US2019091180A1Dosage regimen for a s1p receptor agonistNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1165US2019358178A1Paediatric Compositions For Treating Multiple SclerosisNOVARTIS AG·Filed 2019·Application pending·0 cites
- 1264US11759436B2Dosage regimen of an S1P receptor modulatorNOVARTIS AG·Filed 2020·Granted Sep 19, 2023·0 cites·4 claims
- 1363US2017189353A1Dosage regimen for a s1p receptor agonistNOVARTIS AG·Filed 2017·Application pending·0 cites
- 1463US2019117593A1Paediatric Compositions for Treating Multiple SclerosisNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1562US2014148415A1Dosage regimen for a s1p receptor agonistSCHMOUDER ROBERT·Filed 2014·Application pending·0 cites
- 1661US2014066657A1Dosage regimen for a s1p receptor agonistSCHMOUDER ROBERT·Filed 2013·Application pending·0 cites
- 1761US2011152380A1Paediatric Compositions For Treating Multiple SclerosisKOVARIK JOHN M·Filed 2009·Application pending·0 cites
- 1861US2018177747A1Paediatric Compositions For Treating Multiple SclerosisNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1959US2017333368A1Paediatric Compositions For Treating Multiple SclerosisNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2058US2017128389A1Paediatric Compositions For Treating Multiple SclerosisNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2158US2010160259A1Dosage regimen for a s1p receptor agonistSCHMOUDER ROBERT·Filed 2009·Application pending·0 cites
- 2257US2016263061A1Dosage regimen for a s1p receptor agonistSCHMOUDER ROBERT·Filed 2016·Application pending·0 cites
- 2356US2016081949A1Dosage regimen for a s1p receptor agonistSCHMOUDER ROBERT·Filed 2015·Application pending·0 cites
- 2455US2017304226A1Dosage regimen of an s1p receptor modulatorNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2553US2016206574A1Paediatric Compositions For Treating Multiple SclerosisKOVARIK JOHN M·Filed 2016·Application pending·0 cites
- 2653US2014187516A1Dosage regimen of an s1p receptor modulatorBOULTON CRAIG·Filed 2014·Application pending·0 cites
- 2751US2016022611A1Paediatric Compositions For Treating Multiple SclerosisKOVARIK JOHN M·Filed 2015·Application pending·0 cites
- 2849US2016256416A1Dosage regimen of an s1p receptor modulatorBOULTON CRAIG·Filed 2016·Application pending·0 cites
- 2949US2013230489A1Paediatric Compositions For Treating Multiple SclerosisKOVARIK JOHN M·Filed 2013·Application pending·0 cites
- 3045US2012264719A1Dosage regimen of an s1p receptor modulatorBOULTON CRAIG·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Robert Schmouder files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →